Business Context and Reporting Period
This Form 8-K was filed on August 8, 2007, by PharmAthene, Inc. (formerly Healthcare Acquisition Corp., or "HAQ"). The filing reports the completion of a merger between HAQ's wholly-owned subsidiary, PAI Acquisition Corp., and the privately held PharmAthene, Inc. As a result of this transaction, HAQ changed its name to PharmAthene, Inc., and the private company became a wholly-owned subsidiary named PharmAthene US Corporation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on the corporate restructuring event rather than financial performance data.
Material Changes
- Corporate Name Change: The registrant changed its name from Healthcare Acquisition Corp. to PharmAthene, Inc.
- Corporate Structure: The private company PharmAthene, Inc. is now a wholly-owned subsidiary of the public registrant under the name PharmAthene US Corporation.
- Investor Communication: A conference call was conducted on August 8, 2007, to discuss the merger details.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future financial performance, or specific risk factors. It references a press release (Exhibit 99.1) and a conference call replay for further details regarding the merger.
Key Facts for Investor Verification
- Verify the terms of the merger agreement between PAI Acquisition Corp. and the private PharmAthene, Inc.
- Review the attached press release (Exhibit 99.1) for details on the transaction structure and capitalization.
- Confirm the availability of the conference call replay (passcode: 3318943) for management's perspective on the merger.
- Check subsequent filings for the first financial statements reflecting the combined entity.